Ghent University Academic Bibliography

Journal Article
A1
open access

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.

(2021) MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. 22. p.172-182

Add to list

Journal Article
A1
open access

The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients

Philippe Aftimos, Christian Rolfo, Sylvie Rottey (UGent) , Philippe Barthélémy, Christophe Borg, Keunchil Park, Do-Youn Oh, Sang-We Kim, Natalie De Jonge, Valérie Hanssens, et al.

(2021) BIOMEDICINES. 9(6).

Add to list

Toxicokinetics of alpha-zearalenol and its masked form in rats and the comparative biotransformation in liver microsomes from different livestock and humans

Shupeng Yang (UGent) , Yanshen Li, Marthe De Boevre (UGent) , Sarah De Saeger (UGent) , Jinhui Zhou, Yi Li, Huiyan Zhang and Feifei Sun

(2020) JOURNAL OF HAZARDOUS MATERIALS. 393.

Add to list

A semi-mechanistic population pharmacokinetic/pharmacodynamic model of bortezomib in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Julie M Janssen, TPC Dorlo, D Niewerth, AJ Wilhelm, CM Zwaan, JH Beijnen, A Attarbaschi, A Baruchel, F Fagioli, T Klingebiel, et al.

(2020) CLINICAL PHARMACOKINETICS. 59(2). p.207-216

Add to list

Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition

Roger A. Habets, Charles E. de Bock, Lutgarde Serneels, Inge Lodewijckx, Delphine Verbeke, David Nittner, Rajeshwar Narlawar, Sofie Demeyer, James Dooley, Adrian Liston, et al.

(2019) SCIENCE TRANSLATIONAL MEDICINE. 11(494).

Add to list

Journal Article
A1
open access

Chimeric antigen receptor-T cells for targeting solid tumors : current challenges and existing strategies

Lorraine Springuel, Caroline Lonez, Bertrand Alexandre, Eric Van Cutsem, Jean-Pascal H. Machiels, Marc Van Den Eynde, Hans Prenen, Alain Hendlisz, Leila Shaza, Javier Carrasco, et al.

(2019) BIODRUGS. 33(5). p.515-537

Add to list

Oral selinexor-dexamethasone for triple-class refractory multiple myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, Ajay K. Nooka, Andrew J. Yee, Carol A. Huff, Philippe Moreau, David Dingli, Craig Cole, Sagar Lonial, et al.

(2019) NEW ENGLAND JOURNAL OF MEDICINE. 381(8). p.727-738

Add to list

Journal Article
A1
open access

The anaphase-promoting complex/cyclosome : a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

Anke Maes, Ken Maes, Hendrik De Raeve, Eva De Smedt, Philip Vlummens (UGent) , Vanessa Szablewski, Julie Devin, Sylvia Faict, Kim De Veirman, Eline Menu, et al.

(2019) BRITISH JOURNAL OF CANCER. 120(12). p.1137-1146

Add to list

Journal Article
A1
open access

Preclinical and clinical therapeutic strategies affecting tumor-associated macrophages in hepatocellular carcinoma

Helena Degroote (UGent) , Alex van Dierendonck, Anja Geerts (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2018) JOURNAL OF IMMUNOLOGY RESEARCH.

Add to list

Deglucosylation of zearalenone-14-glucoside in animals and human liver leads to underestimation of exposure to zearalenone in humans

Shupeng Yang (UGent) , Huiyan Zhang, Jinzhen Zhang, Yanshen Li, Yue Jin, Suxia Zhang, Sarah De Saeger (UGent) , Yi Li, Jinhui Zhou, Feifei Sun, et al.

(2018) ARCHIVES OF TOXICOLOGY. 92(9). p.2779-2791

Academic Bibliography

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients

Toxicokinetics of alpha-zearalenol and its masked form in rats and the comparative biotransformation in liver microsomes from different livestock and humans

A semi-mechanistic population pharmacokinetic/pharmacodynamic model of bortezomib in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition

Chimeric antigen receptor-T cells for targeting solid tumors : current challenges and existing strategies

Oral selinexor-dexamethasone for triple-class refractory multiple myeloma

The anaphase-promoting complex/cyclosome : a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

Preclinical and clinical therapeutic strategies affecting tumor-associated macrophages in hepatocellular carcinoma

Deglucosylation of zearalenone-14-glucoside in animals and human liver leads to underestimation of exposure to zearalenone in humans

Contents

Support

Contact